Evidence map›Paper›PMID 32103372›Full record

ArticleClinical rheumatology2020

Investigation of the efficacy of daidzein in experimental knee osteoarthritis-induced with monosodium iodoacetate in rats.

Gulsah Gundogdu, Fatma Demirkaya Miloglu, Koksal Gundogdu, Seymanur Yilmaz Tasci, Mevlut Albayrak, Tuba Demirci, Meltem Cetin

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gulsah GundogduDepartment of Physiology, Pamukkale University, Faculty of Medicine, Denizli, Turkey. gdemirkaya81@gmail.com.ORCID https://orcid.org/0000-0002-9924-5176
Fatma Demirkaya MilogluDepartment of Analytical Chemistry, Ataturk University, Faculty of Pharmacy, Erzurum, Turkey.
Koksal GundogduDepartment of Orthopedics and Traumatology, Denizli State Hospital, Denizli, Turkey.
Seymanur Yilmaz TasciDepartment of Physiology, Ataturk University, Faculty of Medicine, Erzurum, Turkey.
Mevlut AlbayrakDepartment of Medical Laboratory Techniques, Ataturk University, Health Services Vocational College, Erzurum, Turkey.
Tuba DemirciDepartment of Histology and Embryology, Ataturk University, Faculty of Medicine, Erzurum, Turkey.
Meltem CetinDepartment of Pharmaceutical Technology, Ataturk University, Faculty of Pharmacy, Erzurum, Turkey.
Atatürk University · TRDenizli Devlet Hastanesi · TRPamukkale University · TR

Funding

Ataturk Üniversitesi TCD-2018-6146
6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is a degenerative chronic illness that most frequently occurs in the knee joint. Daidzein (DZ) an isoflavone has anti-inflammatory and antioxidant activity. The aim of this study was to evaluate the effectiveness of DZ as a treatment for experimental knee OA (KOA) in rats.

methodAn experimental KOA model was induced by monosodium iodoacetate (MIA) in rats. Thereafter, 49 Wistar albino male rats (250-300 g, 12-16 weeks old) were randomly divided into 7 groups: C (healthy control); DC (KOA + saline); hyaluronic acid (HA); HA+ intraarticular (ia) DZ; oral (po) DZ; ia DZ; HA + po DZ groups. DZ and/or HA were administered intraarticularly to the rats as 50 μL on days 1, 7, 14, and 21. Alternatively, the DZ was administered orally as 0.5 mL twice daily for 21 days. After the treatment, rats were sacrificed by decapitation under general anesthesia. Serum samples were analyzed to determine the total oxidant status (TOS) and total antioxidant status (TAS) and the levels of TNF-α, IL-1β, MMP-13, and DZ. Knee joint samples underwent histopathological examination, and TNF-α, IL-1β, NOS2, and MMP-13 were analyzed with immunohistochemical methods.

resultsHA, DZ, and DZ + HA effectively reduced the levels of TNF-α, IL-1β, and MMP-13 in the serum of the DC group (p < 0.001). In groups that received HA, DZ, or DZ + HA, the serum TAS increased compared with the DC group (p < 0.05). When the DZ + HA combination was used, a more pronounced reduction in the levels of TNFα, NOS2, IL-1β, and MMP-13 was observed in knee joints. In addition, the cracks on the cartilage surface and fibrillation were completely improved in the groups that received HA, DZ, or DZ + HA compared with the DC group.

conclusionDZ had anti-inflammatory and antioxidant effects in a rat OA model. Therefore, DZ, as monotherapy or especially in combination with HA, may be a promising and beneficial therapy for OA. Key Points •DZ has been shown to reduce TNF-α, IL-1β, and MMP-13 both in serum and in tissue samples taken from the knee-joints. •The cracks on the cartilage surface and fibrillation in KOA were completely improved by using DZ and DZ + HA combination. •DZ may be useful to eliminate/reduce/ameliorate inflammation and oxidative damage in the pathogenesis of KOA. •DZ, alone or in combination with HA, may be a promising natural compound with beneficial effects in the treatment of KOA.

Indexed as

AnimalsAntioxidantsCartilage, ArticularHyaluronic AcidInflammationInterleukin-1betaIodoacetatesIsoflavonesKnee JointMaleMatrix Metalloproteinase 13Osteoarthritis, KneeRatsRats, WistarTumor Necrosis Factor-alphaAntioxidantsdaidzeinHyaluronic AcidIL1B protein, humanInterleukin-1betaIodoacetatesIsoflavonesMatrix Metalloproteinase 13Tumor Necrosis Factor-alphaDaidzeinHyaluronic acidInflammationKnee osteoarthritis model

Identifiers

PMID32103372
OpenAlexW3007756076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.